4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000015
Chief Medical Officer sold 2,171 shares at $26.84 ($58,270)
- Chief Medical Officer acquired 2,171 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-03-09 | Option exercise 10b5-1 | +2,171 | $16.00 | $34,736 | 84,660 | D |
| Rodman David Malcom Chief Medical Officer | 2026-03-09 | Sale 10b5-1 | −2,171 | $26.84 | $58,270 | 82,489 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-03-09 | Option exercise · Stock Option 10b5-1 | −2,171 | 23,876 | D | ||
| Open-market sales · 2,171 sh · avg $26.84 · $58,270 | |||||||
Loading xslF345X05/wk-form4_1773179312.xml…